There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.

The US is Australia’s biggest export market for pharmaceuticals. If the tariffs go ahead, manufacturing could suffer.

President Donald Trump’s desire to have unchecked authority over the next wave of Russia sanctions could throw a wrench in ...

Cancer survivors who received high-cost immunotherapies appear more likely to experience financial hardship, according to ...

A 200% tariff rate — even with a delay — will have a detrimental effect on drug prices and profit margins, analysts warn.

Buoyant markets may reflect hopes that the US president will always chicken out of imposing harsh tariffs. Yet Donald Trump ...

With the first steel girders of the $200-million Shoppes at Heritage plaza rising from the ground as a backdrop, an official ...

A son of notorious Mexican drug lord Joaquin “El Chapo” Guzman is expected to plead guilty in a sweeping U.S. drug ...

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

The state law gives Gov. Lamont "an enormous amount of negotiating leverage with the industry," Sen. Lesser said.

Local government employees will face a 36.5% increase in premiums as the health plan continues its 'death spiral,' as many ...